Regulus
Regulus Therapeutics is a California-based biopharmaceutical firm that develops and markets microRNA therapies for the treatment of inflammatory and metabolic disorders.
Business Model:
Revenue: $10M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Regulus Information
Geographic Data
Address: 4224 Campus Point Court
City: San Diego
State: CA
Zip: 92121
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$35M
Raised Total:$349M
Social
Metrics
3,366,178Website Global Rank
4,391Website Monthly Traffic
Twitter Followers
Description
Regulus Therapeutics is a California-based biopharmaceutical firm that develops and markets microRNA therapies for the treatment of inflammatory and metabolic disorders.
Contact Phone:
+18887348587
Contact Email:
Regulus went public on 10/5/2012 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/5/2012
IPO Valuation:
$137M
Ticker Symbol:
RGLS
IPO Price:
$4/share
Amount Raised:
$45M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2014 | Post-IPO Equity | $103.5M | 12/2020 | Private Placement | $19.4M | 5/2019 | Private Placement | $16.7M | 10/2010 | Venture Round | 1 | $10M |
Aventis Capital Aventis Capital |
3/2009 | Series A | $20M | 2/2014 | Post-IPO Equity | $10M | 10/2014 | Post-IPO Equity | $103.5M | 7/2013 | Post-IPO Equity | $49.2M | 7/2017 | Post-IPO Equity | $43M | 12/2020 | Post-IPO Equity | $19.4M | 10/2012 | Post-IPO Debt | $25M | 11/2022 | Post-IPO Equity | $4.5M | 5/2019 | Post-IPO Equity | $16.7M | 11/2021 | Private Placement | 2 | $34.6M |
Federated Kaufmann Fund New Enterprise Associates Federated Kaufmann Fund New Enterprise Associates |
6/2016 | Post-IPO Debt | 1 | $30M |
Oxford Finance LLC Oxford Finance LLC |
4/2023 | Post-IPO Equity | $0 |
Federated Kaufmann Fund New Enterprise Associates Federated Kaufmann Fund New Enterprise Associates Federated Kaufmann Fund New Enterprise Associates Federated Kaufmann Fund New Enterprise Associates |
1/2017 | Post-IPO Equity | 1 | - |
New Enterprise Associates New Enterprise Associates |
1/2017 | Post-IPO Equity | 1 | - |
New Enterprise Associates New Enterprise Associates |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
